Home > Lawyers

Back

Wensheng Ren

Gender:MaleNation:Han
  • Telephone:021-61223818
  • Phone:
  • Fax:021-61223899
  • Post:Lawyers
  • PRACTICE AREAS
    Contract Law;
    The Companies Law;
    Foreign investment;
    Cross-border mergers and acquisitions.
  • PROFESSIONAL QUALIFICATION
    Mar 01,2012,obtained People's Republic of China Legal Profession (Lawyer) Qualification Certificate
  • LICENSE NUMBER
    13101202310713718
  • EDUCATIONAL BACKGROUND
    LL.M., Shanghai University of Finance and Economics
  • PRACTICE EXPERIENCE
    Wensheng is a corporate Counsel at Hogan Lovells Fidelity (Shanghai), focusing on domestic and cross-border mergers and acquisitions, joint ventures, restructurings, and other complex corporate matters. He also advises on licensing and collaboration agreements and other strategic commercial agreements. Wensheng has represented a broad range of clients in a variety of industries, including life sciences, technology, financial services, automotive, industrial and consumer and retail.
    Recognized by The Legal 500, Wensheng regularly earns plaudits from his clients, noting that “his customer service is top-notch. He's prompt, knowledgeable and very respectful of and familiar with our processes” and “I always appreciate [his] diligence and responsiveness. No one does it better (and we work with a lot of outside counsel)!”
    Representative experience

    Wensheng’s notable transactions include representing:
    Jiangsu Jinsheng in its sale of certain EU businesses to Rieter Holding AG
    Synopsys in its joint venture in the energy vertical market in China
    Medtronic in its spin-off of OEM business from Kanghui
    Willis Towers Watson in its sale of reinsurance brokerage business and its buyout of the Chinese partner
    PPG in its acquisition of powder coating business in China
    Dana Incorporated in its acquisition of SME Group
    Booking.com in its sale of customer service centers to Majorel
    REEL International in its acquisition of Metso Outotec
    Lion Brothers in its sale to Avery Dennison
    Google in its US$550 million investment in JD.com
    Sesen Bio in its licensing agreement with Qilu Pharmaceutical
    Novartis in its licensing and supply arrangement with Grand Pharmaceutical
    Insulet in its contract manufacturing arrangement in China
    Insightec in its strategic partnership with Fosun Pharma
  • WORKING LANGUAGE
    Chinese,English.